Should you worry about AstraZeneca Covishield

AstraZeneca admits that Covishield may be linked to the uncommon blood clot condition.

Image Credit: Getty Image

This condition called Thrombosis Thrombocytopenia Syndrome (TTS).

Image Credit: Getty Image

Health professionals say that TTS dangers are small in comparison to Covishield's advantages.

Image Credit: Getty Image

Covishield is a vaccination that works via a virus.

Image Credit: Getty Image

Serum Institute of India partnered with AstraZeneca to produce Covishield, widely used in India.

Image Credit: Getty Image

TTS incidence is about one in 50,000 vaccinated individuals.

Image Credit: Getty Image

TTS symptoms include severe headaches, abdominal pain, and requires anticoagulation therapy.

Image Credit: Getty Image

51 UK court cases claim Covishield caused death and serious injury.

Image Credit: Getty Image

TTS leads to blood clots and low platelet count.

Image Credit: Getty Image

WHO reported on TTS linked to adenovirus vector vaccines in 2021.

Image Credit: Getty Image